Interview with CEO Dr. Chris Chen of WuXi Biologics
Quality Assurance Evolution in the Biopharmaceutical CDMO Industry – stricter regulations, technological advancements, risk management, globalisation and client expe...
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.